drugset / Trial / NCT05977998
A Phase II Study of Perioperative Paclitaxel in Patients With Gastric Adenocarcinoma and Carcinomatosis or Positive Cytology
NaSingle-groupOpen-labelTreatment
Summary
To learn about the effects of paclitaxel and gastrectomy (surgery to remove all or part of the stomach) on improving outcomes in patients with gastric cancer.
Timeline
- Start
- 2023-09-08
- Primary completion
- 2028-10-31
- Completion
- 2030-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Paclitaxel | Small molecule | — | Other |
| Background | Dexamethasone | Small molecule | — | Intravenous |
| Background | Diphenhydramine | Unknown | — | Intravenous |
| Background | Famotidine | Other / unclassified | — | Intravenous |